Pteryxin exhibits significant anti-inflammatory and analgesic properties, making it valuable in the development of pain-relief medications. It is studied for its potential to inhibit key enzymes involved in inflammatory pathways, such as cyclooxygenase (COX) and lipoxygenase (LOX), which are targets for non-steroidal anti-inflammatory drugs (NSAIDs). Additionally, pteryxin shows promise in cancer research due to its ability to induce apoptosis in certain tumor cell lines, particularly in breast and liver cancers. Its natural origin and low toxicity profile support its use in herbal medicine formulations, especially in traditional systems where plant extracts are used to treat fever, pain, and skin conditions. Ongoing research explores its neuroprotective effects, suggesting possible applications in managing neurodegenerative diseases like Alzheimer’s.